DK162130C - Grf-analoge peptider, fremgangsmaade til fremstilling deraf, grf-analoge peptider som terapeutiske midler, anvendelse af grf-analoge peptider, fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende grf-analoge peptider samt parenterale farmaceutiske praeparater indeholdende grf-analoge peptider - Google Patents

Grf-analoge peptider, fremgangsmaade til fremstilling deraf, grf-analoge peptider som terapeutiske midler, anvendelse af grf-analoge peptider, fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende grf-analoge peptider samt parenterale farmaceutiske praeparater indeholdende grf-analoge peptider

Info

Publication number
DK162130C
DK162130C DK151884A DK151884A DK162130C DK 162130 C DK162130 C DK 162130C DK 151884 A DK151884 A DK 151884A DK 151884 A DK151884 A DK 151884A DK 162130 C DK162130 C DK 162130C
Authority
DK
Denmark
Prior art keywords
grf
analog peptides
grf analog
pharmaceutical preparations
preparations containing
Prior art date
Application number
DK151884A
Other languages
English (en)
Other versions
DK162130B (da
DK151884D0 (da
DK151884A (da
Inventor
Arthur M Felix
Edgar P Heimer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK151884D0 publication Critical patent/DK151884D0/da
Publication of DK151884A publication Critical patent/DK151884A/da
Publication of DK162130B publication Critical patent/DK162130B/da
Application granted granted Critical
Publication of DK162130C publication Critical patent/DK162130C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK151884A 1983-03-07 1984-03-05 Grf-analoge peptider, fremgangsmaade til fremstilling deraf, grf-analoge peptider som terapeutiske midler, anvendelse af grf-analoge peptider, fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende grf-analoge peptider samt parenterale farmaceutiske praeparater indeholdende grf-analoge peptider DK162130C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47270083A 1983-03-07 1983-03-07
US47270083 1983-03-07

Publications (4)

Publication Number Publication Date
DK151884D0 DK151884D0 (da) 1984-03-05
DK151884A DK151884A (da) 1984-09-08
DK162130B DK162130B (da) 1991-09-23
DK162130C true DK162130C (da) 1992-03-02

Family

ID=23876594

Family Applications (1)

Application Number Title Priority Date Filing Date
DK151884A DK162130C (da) 1983-03-07 1984-03-05 Grf-analoge peptider, fremgangsmaade til fremstilling deraf, grf-analoge peptider som terapeutiske midler, anvendelse af grf-analoge peptider, fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende grf-analoge peptider samt parenterale farmaceutiske praeparater indeholdende grf-analoge peptider

Country Status (11)

Country Link
EP (1) EP0121764B1 (da)
JP (1) JPH0786120B2 (da)
AT (1) ATE53220T1 (da)
AU (1) AU574064B2 (da)
CA (1) CA1254000A (da)
DE (1) DE3482387D1 (da)
DK (1) DK162130C (da)
IE (1) IE57097B1 (da)
IL (1) IL71150A (da)
NZ (1) NZ207378A (da)
ZA (1) ZA841638B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70530A (en) * 1983-01-13 1986-09-30 Salk Inst For Biological Studi Synthetic peptides having growth hormone releasing factor activity and compositions containing them
US4518586A (en) * 1983-01-13 1985-05-21 The Salk Institute For Biological Studies GRF Analogs III
BG49718A3 (bg) * 1983-07-15 1992-01-15 Bio- Technology General Corp Метод за получаване на полипептид със супероксиддисмутазна активност
DE3327007A1 (de) * 1983-07-27 1985-02-07 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit einem saeureamid-carboxyterminus
AU575843B2 (en) * 1983-08-10 1988-08-11 The Administrators Of The Tulane Eductional Fund Growth hormone releasing peptides
US4617149A (en) * 1983-09-21 1986-10-14 Eli Lilly And Company Growth hormone release factor analogs
CA1340265C (en) * 1985-01-18 1998-12-15 Kirston E. Koths Oxidation resistant muteins
US4734399A (en) * 1985-08-06 1988-03-29 Hoffmann-La Roche Inc. Growth hormone releasing factor analogs
ES2001203A6 (es) * 1985-08-12 1988-05-01 Syntex Inc Procedimiento para preparar el polipeptido factor liberador de la hormona del crecimiento bovina
EP0448513A3 (en) * 1990-03-21 1991-12-27 Japat Ltd Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof
ZA914983B (en) * 1990-06-29 1992-03-25 Hoffmann La Roche His-grf-analogs
ATE119916T1 (de) * 1990-12-10 1995-04-15 Hoffmann La Roche Verfahren zur enzymatischen herstellung von grf(1-44)nh2.
EP0525838A3 (en) * 1991-04-09 1993-02-10 F. Hoffmann-La Roche Ag Growth hormone releasing factor analogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70530A (en) * 1983-01-13 1986-09-30 Salk Inst For Biological Studi Synthetic peptides having growth hormone releasing factor activity and compositions containing them
US4617149A (en) * 1983-09-21 1986-10-14 Eli Lilly And Company Growth hormone release factor analogs

Also Published As

Publication number Publication date
JPH0786120B2 (ja) 1995-09-20
DE3482387D1 (en) 1990-07-05
AU574064B2 (en) 1988-06-30
IE57097B1 (en) 1992-04-22
DK162130B (da) 1991-09-23
JPS59176238A (ja) 1984-10-05
DK151884D0 (da) 1984-03-05
EP0121764A2 (de) 1984-10-17
NZ207378A (en) 1989-05-29
AU2526884A (en) 1984-09-13
CA1254000A (en) 1989-05-09
EP0121764B1 (de) 1990-05-30
EP0121764A3 (en) 1985-12-04
IL71150A (en) 1987-02-27
DK151884A (da) 1984-09-08
ATE53220T1 (de) 1990-06-15
IE840537L (en) 1984-09-07
ZA841638B (en) 1984-10-31
IL71150A0 (en) 1984-06-29

Similar Documents

Publication Publication Date Title
DE68928810D1 (de) Analoge vom menschlichen Insulin
DK601786A (da) Hidtil ukendte prokoagulationsproteiner
ES8802129A1 (es) Procedimiento para preparar un analogo polipeptido inhibidorde resina
AU574064B2 (en) Growth hormone releasing factor analogues
IL85020A0 (en) Pancreatic secretory trypsin inhibitor and variants thereof,process expression vector and recombinant host therefor and pharmaceutical compositions containing it
DE69525544D1 (de) Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
EP0346500A4 (en) Elastase inhibiting polypeptides and process for their preparation by genetic recombination
ATE111483T1 (de) Biologisch wirksame moleküle.
KR890010202A (ko) 사람 단백질 c의 지모겐 형태의 발현용 벡터 및 화합물
ATE68827T1 (de) Herstellung von polypeptiden mit einem saeureamid- carboxyterminus.
DE3751398D1 (de) Substrat-Peptide.
DE3650035D1 (de) THF-Zusammensetzungen.
GB1002041A (en) New polypeptides and process for their manufacture
ATE91286T1 (de) Gefaessaktive peptide.
LI et al. Distinct behavior of β‐endorphin and corticotropin toward leucine aminopeptidase action
ATE106944T1 (de) Rekombinante polypeptide des hämorrhagischen fisch-sepsis-virus.
CA1267086C (en) METHOD OF ADMINISTRATION OF EAR DIURETIC PEPTIDES
DE59008515D1 (de) Neue ZNS-aktive Hexapeptide mit antiamnestischer Wirkung.

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed